4//SEC Filing
Cheruvu Pavan 4
Accession 0001636050-19-000084
CIK 0001636050other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:14 PM ET
Size
5.8 KB
Accession
0001636050-19-000084
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Award
Restricted Stock Units
2019-09-21+45,181→ 45,181 total→ Common Shares (45,181 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- [F2]50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date.
Documents
Issuer
Axovant Gene Therapies Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001731741
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:14 PM ET
- Size
- 5.8 KB